ReviewFrontiers in immunology2026

Pharmacological intervention of the HMGB1-pCTS-L axis to ameliorate inflammatory diseases.

Weiqiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.